Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | TGTX |
---|---|---|
09:32 ET | 37718 | 18.85 |
09:34 ET | 64457 | 18.61 |
09:36 ET | 18850 | 18.65 |
09:38 ET | 15979 | 18.58 |
09:39 ET | 8483 | 18.8 |
09:41 ET | 9374 | 18.7 |
09:43 ET | 17354 | 18.73 |
09:45 ET | 13025 | 18.75 |
09:48 ET | 14336 | 18.76 |
09:50 ET | 16626 | 18.78 |
09:52 ET | 19911 | 18.97 |
09:54 ET | 7916 | 18.86 |
09:56 ET | 6164 | 18.9 |
09:57 ET | 4555 | 18.9552 |
09:59 ET | 2023 | 18.93 |
10:01 ET | 13440 | 18.98 |
10:03 ET | 15435 | 18.99 |
10:06 ET | 17534 | 19.03 |
10:08 ET | 5903 | 18.99 |
10:10 ET | 6407 | 18.92 |
10:12 ET | 6382 | 18.9029 |
10:14 ET | 13135 | 18.8898 |
10:15 ET | 9645 | 18.84 |
10:17 ET | 5705 | 18.84 |
10:19 ET | 15938 | 18.76 |
10:21 ET | 21235 | 18.69 |
10:24 ET | 19110 | 18.71 |
10:26 ET | 6944 | 18.73 |
10:28 ET | 7258 | 18.73 |
10:30 ET | 11968 | 18.6677 |
10:32 ET | 6469 | 18.68 |
10:33 ET | 9237 | 18.64 |
10:35 ET | 26036 | 18.58 |
10:37 ET | 35693 | 18.6 |
10:39 ET | 1750 | 18.62 |
10:42 ET | 6225 | 18.6211 |
10:44 ET | 4023 | 18.65 |
10:46 ET | 9134 | 18.585 |
10:48 ET | 13325 | 18.6 |
10:50 ET | 1853 | 18.59 |
10:51 ET | 5459 | 18.565 |
10:53 ET | 26688 | 18.56 |
10:55 ET | 5598 | 18.595 |
10:57 ET | 3823 | 18.58 |
11:00 ET | 10738 | 18.58 |
11:02 ET | 2543 | 18.63 |
11:04 ET | 10256 | 18.6 |
11:06 ET | 12236 | 18.63 |
11:08 ET | 3456 | 18.6521 |
11:09 ET | 2999 | 18.63 |
11:11 ET | 39509 | 18.565 |
11:13 ET | 3183 | 18.58 |
11:15 ET | 4524 | 18.55 |
11:18 ET | 7261 | 18.59 |
11:20 ET | 824 | 18.6 |
11:22 ET | 3091 | 18.6 |
11:24 ET | 600 | 18.61 |
11:26 ET | 6507 | 18.67 |
11:27 ET | 6250 | 18.65 |
11:29 ET | 2600 | 18.625 |
11:31 ET | 3352 | 18.64 |
11:33 ET | 3163 | 18.62 |
11:36 ET | 24665 | 18.58 |
11:38 ET | 14831 | 18.575 |
11:40 ET | 2751 | 18.58 |
11:42 ET | 5096 | 18.55 |
11:44 ET | 9984 | 18.57 |
11:45 ET | 1726 | 18.58 |
11:47 ET | 3368 | 18.58 |
11:49 ET | 3684 | 18.63 |
11:51 ET | 5344 | 18.62 |
11:54 ET | 1253 | 18.64 |
11:56 ET | 11069 | 18.68 |
11:58 ET | 2627 | 18.67 |
12:00 ET | 2727 | 18.61 |
12:02 ET | 30451 | 18.65 |
12:03 ET | 6350 | 18.61 |
12:05 ET | 17423 | 18.57 |
12:07 ET | 2221 | 18.612 |
12:09 ET | 417 | 18.6 |
12:12 ET | 2215 | 18.5694 |
12:14 ET | 300 | 18.56 |
12:16 ET | 3330 | 18.555 |
12:18 ET | 16087 | 18.51 |
12:20 ET | 30104 | 18.37 |
12:21 ET | 10490 | 18.364 |
12:23 ET | 15114 | 18.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
TG Therapeutics Inc | 3.0B | 83.4x | --- |
Twist Bioscience Corp | 2.8B | -14.1x | --- |
MorphoSys AG | 2.7B | -5.4x | --- |
Arrowhead Pharmaceuticals Inc | 3.3B | -6.3x | --- |
ADMA Biologics Inc | 2.6B | -527.9x | --- |
Denali Therapeutics Inc | 3.2B | -22.8x | --- |
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.24 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 83.4x |
Price/Sales (TTM) | 10.3 |
Price/Cash Flow (TTM) | 71.7x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.